Re: Long-Term Outcomes in Patients with Muscle-Invasive Bladder Cancer after Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

Documenti analoghi

• Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
  di: Mak, Raymond H., et al.
  Pubblicazione: (2014)
• Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival
  di: Lautenschlaeger, Tim, et al.
  Pubblicazione: (2013)
• Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233
  di: Mitin, Timur, et al.
  Pubblicazione: (2015)
• In favour of bladder preservation using combined modality treatment
  di: Lukka, Himu
  Pubblicazione: (2009)
• Invasive Bladder Cancer: The Role of Bladder Preserving Therapy
  di: Seyed Yousef Hosseini
  Pubblicazione: (2005-05-01)